跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tanzase - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tanzase
Approved
STANDARD
Tanzase
PharmaEvo Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5caae47f57811536
Company
PharmaEvo Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
5caae47f57811536
Drug Approval Philippines Name
Tanzase
Product Name
Tanzase
Registration Number
DRP-5768
Brand Name
Tanzase
Generic Name
Losartan Potassium
Dosage Form
Tablet
Dosage Strength
50 mg
Manufacturer
PharmaEvo Pvt. Ltd.
Importer
RBCJ Pharmacy
Distributor
RBCJ Pharmacy
Issuance Date
28 June 2023
Expiry Date
04 December 2028
Pharmacologic Category
Angiotensin-2-Receptor Blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5caae47f57811536
Type
Standard
Back to Philippines FDA Approvals